KATRINA HAZLETT: Open Payments
NPI 1023764792 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 45 payments from 22 companies in 2025. Trend: 2023 $40 · 2024 $427 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $135 |
| ABBVIE INC. | 4 | $119 |
| Lilly USA, LLC | 5 | $101 |
| Novo Nordisk Inc | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| SANOFI-AVENTIS U.S. LLC | 2 | $58 |
| Sumitomo Pharma America, Inc. | 1 | $56 |
| Amgen Inc. | 2 | $47 |
Products named: DOVATO, REXULTI, UBRELVY, MOUNJARO, TZIELD, GEMTESA, NURTEC ODT, Kerendia.
Industry payments across CO — which companies pay providers there.
